Related Experiment Video
Updated: Oct 11, 2025

Isolation of Human Mesenchymal Stem Cells and their Cultivation on the Porous Bone Matrix
Published on: February 9, 2015
Comprehensive analysis of human chorionic membrane extracts regulating mesenchymal stem cells during osteogenesis
Yoon Young Go1,2, Sung-Won Chae1, Jae-Jun Song1,2
1Department of Otorhinolaryngology-Head and Neck Surgery, Korea University Guro Hospital, Seoul, Republic of Korea.
Human chorionic membrane extracts (CMEs) promote bone regeneration by enhancing osteoblast activity. These extracts contain growth factors and signaling molecules that activate pathways crucial for bone formation.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Cell Biology
Background:
- Human chorionic membrane extracts (CMEs) are recognized for their osteogenic potential in bone regeneration.
- The precise regulatory mechanisms underlying CME's efficacy remain largely uncharacterized.
Purpose of the Study:
- To elucidate the functional role and underlying molecular mechanisms of CMEs in osteoblast osteogenesis.
- To explore the potential of CMEs as a therapeutic biomaterial for bone regeneration.
Main Methods:
- In vitro studies using human osteoblasts and in vivo bone defect animal models.
- Proteomic analysis to identify key osteogenic proteins within CMEs.
- Microarray analysis to investigate cellular signaling pathways involved in osteogenesis.
Main Results:
- CMEs demonstrated significant in vitro and in vivo bone-forming capabilities.
- Proteomic analysis identified osteopontin, osteomodulin, Thy-1, netrin 4, retinol-binding protein, DJ-1, and 23 growth factors in CMEs.
- Microarray analysis revealed involvement of chemokine, Wnt signaling, angiogenesis, and ossification networks, suggesting a non-canonical Wnt-mediated CXCL signaling pathway.
Conclusions:
- CMEs provide an osteoconductive environment and stimulate osteogenesis through identified proteins and growth factors.
- CMEs may promote osteogenic differentiation via a non-canonical Wnt-mediated CXCL signaling-dependent pathway.
- CMEs represent a novel, biocompatible therapeutic strategy for enhancing bone regeneration.
More Related Videos
12:40Isolation and Expansion of Mesenchymal Stem/Stromal Cells Derived from Human Placenta Tissue
Published on: June 6, 2016
06:47Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018